Why does null hypothesis testing matter for antibody panel validation?

Null hypothesis testing ensures that observed multiplex immunofluorescence signals in FFPE tissues are statistically significant and not due to random variation, supporting robust target validation. This statistical rigor underpins confidence in spatial proteomics outputs for portfolio decision-making. Reliable hypothesis testing reduces the risk of advancing non-informative biomarkers.

How does independent variable isolation fit the multiplex imaging workflow?

Isolating independent variables, such as specific antibody targets or treatment conditions, enables clear attribution of spatial proteomics changes to experimental interventions. This clarity is essential for mechanistic de-risking and supports reproducible discovery-stage findings. It also facilitates cross-study comparisons within the imaging pipeline.

What do quantitative cell segmentation and spatial metrics enable?

Quantitative cell segmentation and spatial metrics allow precise measurement of cell phenotypes, interactions, and distributions within the tumor microenvironment. These outputs inform functional target validation and support predictive modeling of immune responses. They also enable standardized data integration across preclinical studies.

Why are replication requirements critical for antibody panel development?

Replication ensures that multiplex antibody panels yield consistent and reproducible imaging results across FFPE specimens and experimental runs. This reliability is vital for cross-functional collaboration and downstream translational research. Consistent replication underpins confidence in spatial proteomics data for portfolio advancement.

What statistical analysis capabilities are needed before spatial proteomics implementation?

Robust statistical analysis capabilities, including cell population quantification and spatial metric comparison, are required to validate imaging outputs and support decision-making. These analyses enable teams to distinguish true biological effects from technical variability. Comprehensive analytics are essential for integrating spatial proteomics into enterprise R&D workflows.

DNAバーコードを用いたマルチプレックス免疫蛍光イメージングによる、遺伝的に再プログラムされたマウス黒色腫のFFPE検体を解析

1.4K 閲覧数

09:58 分

2025年6月6日

10.3791/68124-v

2025年6月6日

1.4K 閲覧数

Sachin S. Surwase^*¹^,²^,³ , Xin Ming M. Zhou^*³^,⁴ , Kathryn M. Luly¹^,²^,³ , Qingfeng Zhu⁵^,⁶^,⁷ , Niki Talebian⁶ , Robert A. Anders⁵^,⁶^,⁷^,⁸^,⁹ , Jordan J. Green¹^,²^,³^,⁵^,⁸^,⁹^,¹⁰^,¹¹^,¹² , Stephany Y. Tzeng¹^,²^,³ , Joel C. Sunshine¹^,³^,⁴^,⁵^,⁶^,⁸^,⁹

^* These authors contributed equally

このプロトコールは、マウスFFPE黒色腫組織のDNAバーコードベースのイメージングのためのマルチプレックス免疫蛍光抗体パネルを設計するためのステップバイステップガイドを提供します。また、マウスの黒色腫腫瘍免疫微小環境に対する空間的プロテオミクスの洞察を生成するためのオープンソースツールを使用した画像解析パイプラインについても説明します。